Evidence map›Paper›PMID 33262327›Full record

ArticleTranslational psychiatry2020

Autism-associated miR-873 regulates ARID1B, SHANK3 and NRXN2 involved in neurodevelopment.

Jing Lu, Yan Zhu, Sarah Williams, Michelle Watts, Mary A Tonta, Harold A Coleman, Helena C Parkington, Charles Claudianos

Open access · goldAbstract read
In one paragraph

Article in Translational psychiatry, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
1.2field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 29 citations in OpenAlex.

  1. Article
  2. A De NovoInternational journal of molecular sciences · 2026
    Article
  3. Article
  4. IGF2BP3 Promoted the Overproliferation of AML Cells via Stability ofTurkish journal of haematology : official journal of Turkish Society of Haematology · 2026
    Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Review
  12. Decoding microRNAs in autism spectrum disorder.Molecular therapy. Nucleic acids · 2022
    Review
  13. Review
  14. Review
  15. Article
  16. Emerging Role of Non-coding RNAs in Autism Spectrum Disorder.Journal of molecular neuroscience : MN · 2022
    Review
  17. Article
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 5 institutions in 2 countries.

Jing LuMonash Biomedicine Discovery Institute, Monash University, Melbourne, VIC, 3800, Australia. jing.lu2@monash.edu.ORCID 0000-0002-5834-7942
Yan ZhuMonash Biomedicine Discovery Institute, Monash University, Melbourne, VIC, 3800, Australia.ORCID 0000-0001-7342-3782
Sarah WilliamsMonash Bioinformatics Platform, Monash University, Melbourne, VIC, 3800, Australia.
Michelle WattsQueensland Brain Institute, The University of Queensland, Brisbane, QLD, 4072, Australia.ORCID 0000-0002-3178-3429
Mary A TontaMonash Biomedicine Discovery Institute, Monash University, Melbourne, VIC, 3800, Australia.
Harold A ColemanMonash Biomedicine Discovery Institute, Monash University, Melbourne, VIC, 3800, Australia.
Helena C ParkingtonMonash Biomedicine Discovery Institute, Monash University, Melbourne, VIC, 3800, Australia.
Charles ClaudianosMonash Biomedicine Discovery Institute, Monash University, Melbourne, VIC, 3800, Australia. Charles.Claudianos@anu.edu.au.ORCID 0000-0002-9799-9572
Australian Regenerative Medicine Institute · AUAustralian National University · AUDiscovery Institute · USMonash University · AUThe University of Queensland · AU

Funding

Department of Health | National Health and Medical Research Council (NHMRC) APP1008125
6 · The paper itself

Abstract

Autism spectrum disorders (ASD) are highly heritable neurodevelopmental disorders with significant genetic heterogeneity. Noncoding microRNAs (miRNAs) are recognised as playing key roles in development of ASD albeit the function of these regulatory genes remains unclear. We previously conducted whole-exome sequencing of Australian families with ASD and identified four novel single nucleotide variations in mature miRNA sequences. A pull-down transcriptome analysis using transfected SH-SY5Y cells proposed a mechanistic model to examine changes in binding affinity associated with a unique mutation found in the conserved 'seed' region of miR-873-5p (rs777143952: T > A). Results suggested several ASD-risk genes were differentially targeted by wild-type and mutant miR-873 variants. In the current study, a dual-luciferase reporter assay confirmed miR-873 variants have a 20-30% inhibition/dysregulation effect on candidate autism risk genes ARID1B, SHANK3 and NRXN2 and also confirmed the affected expression with qPCR. In vitro mouse hippocampal neurons transfected with mutant miR-873 showed less morphological complexity and enhanced sodium currents and excitatory neurotransmission compared to cells transfected with wild-type miR-873. A second in vitro study showed CRISPR/Cas9 miR-873 disrupted SH-SY5Y neuroblastoma cells acquired a neuronal-like morphology and increased expression of ASD important genes ARID1B, SHANK3, ADNP2, ANK2 and CHD8. These results represent the first functional evidence that miR-873 regulates key neural genes involved in development and cell differentiation.

Indexed as

Autism Spectrum DisorderAutistic DisorderMicroRNAsAnimalsMiceMicrofilament ProteinsNerve Tissue ProteinsTranscription FactorsArid1b protein, mouseMicrofilament ProteinsMicroRNAsMIRN873 microRNA, mouseNerve Tissue ProteinsShank3 protein, mouseTranscription Factors

Identifiers

PMID33262327
PMCPMC7708977
OpenAlexW3108476631

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.